Altius Institute for Biomedical Sciences

Biography - Dr. John S.

Dr. John A. Stamatoyannopoulos is a Professor of Medicine and Genome Sciences at the University of Washington School of Medicine in Seattle, Washington.

He holds degrees in Biological Sciences, Symbolic Systems, and Classics from Stanford University, and an M.D. from the University of Washington School of Medicine.

He completed his medical training at Harvard Medical School, including internship and residency in Internal Medicine at Brigham and Women's Hospital, and fellowship in Oncology and Hematology at the Dana Farber Cancer Institute and Massachusetts General Hospital.

Dr. Stamatoyannopoulos' laboratory is internationally known for its work on mapping and decoding the instructions in the human genome that regulate the activity of human genes, and for developing new molecular and computational technologies for analyzing the structure and function of the living genome.

He is Director of the Northwest Epigenome Center, the UW ENCODE Project Center, and the UW High-Throughput Genomics Center.  Dr. Stamatoyannopoulos has published over 100 papers in top-tier scientific journals, and delivered over 200 invited lectures nationally and internationally. He also serves on numerous advisory panels for major public genomics projects.


Biography - Dr. Lon C.

Dr Lon Cardon, Ph.D. serves as Senior Vice President of Alternative Discovery and Development and Head of Target Sciences at GlaxoSmithKline.

His division is responsible for developing research programs in new disease areas for GSK such as ophthalmology and rare diseases, embedding novel delivery modalities including oligonucleotide and gene therapy, and incubating non-traditional research paradigms, particularly in the interface between academia, biotechnology and big pharma.

He is a member of the R&D executive team and chairs the governance body responsible for all discovery investment.  He initially joined GSK in 2008 as SVP of Genetics, then leading a new platform division, Quantitative Sciences, which combined Genetics with the departments of Statistics, Epidemiology, Computational Biology and Clinical Pharmacokinetics. 

Prior to 2008, Lon was a senior academic in the UK and US, as Professor of Bioinformatics at the University of Oxford until 2006 and then as Professor of Biostatistics at the University of Washington and Fred Hutchinson Cancer Research Center. 

He received his Ph.D. from the Institute for Behavioral Genetics at the University of Colorado and conducted his postdoctoral research in the Department of Mathematics at Stanford University.

He has been awarded a Wellcome Trust Principal Fellowship and is an elected Fellow of the UK’s Academy of Medical Sciences and the American Association for the Advancement of Science. 

He has authored more than 200 scientific publications and 15 books and chapters, mainly focused on statistical genetics methodology and applications for many rare and common diseases, ranging from Huntington’s disease to dyslexia.